13 terminated. 13 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 13 | Terminated 13 |
| Phase 2 | 3 | Terminated 3 |
Follow Apnea: new trials by email Literature Review of Apnea trials Research Report on Apnea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Montelukast for Patients With Obstructive Sleep Apnea Syndrome Montelukast 10mg, Placebo - Sleep Apnea, Obstructive | Phase 3 | Terminated | University Hospital, Grenoble | 1 | 2019-11-29 | 2021-02-17 |
| Sleep Apnea and Fetal Growth Restriction S9 VPAP Adapt - Obstructive Sleep Apnea, Fetal Growth Restriction | Phase 3 | Terminated | Washington University School of Medicine | 3 | 2019-11-18 | 2022-03-09 |
| The Impact of Low Flow Nocturnal Oxygen Therapy on Hospital Admissions and Mortality in Patients With Heart Failure and Central Sleep Apnea Oxygen, Room Air - Heart Failure, Central Sleep Apnea | Phase 3 | Terminated | Brigham and Women's Hospital | 98 | 2019-04-15 | 2023-08-01 |
| Moderately Preterm Infants With Caffeine at Home for Apnea (MoCHA) Trial Caffeine Citrate, Placebo - Apnea of Prematurity | Phase 3 | Terminated | NICHD Neonatal Research Network | 827 | 2019-02-27 | 2024-07-31 |
| Intraoperative Low-dose Ketamine Infusion for Patients With Obstructive Sleep Apnea Ketamine, Control - Sleep Apnea, Obstructive Sleep Apnea | Phase 2 / Phase 3 | Terminated | University of Alabama at Birmingham | 9 | 2016-06-02 | 2019-12-19 |
| Morphine in Moderate Obstructive Sleep Apnoea Morphine sulphate - Obstructive Sleep Apnoea | Phase 3 | Terminated | Papworth Hospital NHS Foundation Trust | 6 | 2016-05-20 | 2018-11-29 |
| OneShot Renal Denervation Registry OneShot Ablation System - Hypertension, Heart Failure | Phase 2 / Phase 3 | Terminated | Medtronic Endovascular | 51 | 2014-07-01 | 2015-09-02 |
| Right to Left Cardiac Shunt Detection Flow Detection System - Right to Left Shunt, Patent Foramen Ovale | Phase 3 | Terminated | Cardiox Corporation | 141 | 2012-11-01 | 2015-11-13 |
| Clinical Trial of Desmopressin on Nocturia in Obstructive Sleep Apnoea Patients Desmopressin, Placebo - Nocturia, Obstructive Sleep Apnoea | Phase 3 | Terminated | Chinese University of Hong Kong | 9 | 2012-03-01 | 2015-02-04 |
| Inhalation of Low Concentration of CO2 in Preterm Infants Not Responding to Caffeine for the Treatment of Apnea Inhalation of low concentration of CO2 - Apnea of Prematurity | Phase 2 / Phase 3 | Terminated | University of Manitoba | 7 | 2011-10-01 | 2015-02-19 |
| Apnex Clinical Study of the Hypoglossal Nerve Stimulation (HGNS®) System to Treat Obstructive Sleep Apnea Hypoglossal Nerve Stimulation (HGNS) System (Apnex Medical ) - Obstructive Sleep Apnea | Phase 3 | Terminated | Apnex Medical, Inc. | 132 | 2011-08-01 | 2015-04-15 |
| Buspirone as a Potential Treatment for Recurrent Central Apnea Acetazolamide, Buspirone - Central Apnea, Heart Failure | Phase 3 | Terminated | VA Office of Research and Development | 8 | 2008-09-01 | 2016-03-14 |
| Modafinil to Treat Fatigue in Post-Polio Syndrome Modafinil - Postpoliomyelitis Syndrome | Phase 3 | Terminated | National Institute of Neurological Disorders and Stroke (NINDS) | 30 | 2003-08-01 | 2008-08-27 |
Sleep Apnea, Obstructive (7) · Sleep Apnea Syndromes (5) · Heart Failure (3) · Sleep Apnea, Central (3) · Agnosia (1) · Asthenia (1) · Cheyne-Stokes Respiration (1) · Depression (1) · Diabetes Mellitus (1) · Epilepsy (1) · Fetal Growth Retardation (1) · Foramen Ovale, Patent (1) · Heart Septal Defects, Atrial (1) · Hypercapnia (1)
Respiration Disorders (13) · Respiratory Tract Diseases (13) · Dyssomnias (11) · Nervous System Diseases (11) · Sleep Disorders, Intrinsic (11) · Sleep Wake Disorders (10) · Pathological Conditions, Signs and Symptoms (8) · Signs and Symptoms (6) · Sleep Apnea Syndromes (6) · Cardiovascular Diseases (4) · Heart Diseases (4) · Signs and Symptoms, Respiratory (4) · Neurologic Manifestations (3) · Pathologic Processes (3)
Acetazolamide (1) · Buspirone (1) · Deamino Arginine Vasopressin (1) · Drug Delivery Systems (1) · Ketamine (1) · Modafinil (1) · Morphine (1) · Oxygen (1) · caffeine citrate (1) · montelukast (1)
Apnex Medical, Inc. (1) · Brigham and Women's Hospital (1) · Cardiox Corporation (1) · Chinese University of Hong Kong (1) · Medtronic Endovascular (1) · NICHD Neonatal Research Network (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · Papworth Hospital NHS Foundation Trust (1) · University Hospital, Grenoble (1) · University of Alabama at Birmingham (1) · University of Manitoba (1) · VA Office of Research and Development (1) · Washington University School of Medicine (1)
United States (8) · Australia (1) · Canada (1) · France (1) · Hong Kong (1) · Israel (1) · Italy (1) · United Kingdom (1)
Alexander Hincker, MD (1) · Eddie SY Chan (1) · Ian Smith, MBBS (1) · Kingman P. Strohl, MD (1) · Martina Mason, MBBS (1) · Michael W Jopling, MD (1) · Peter A Nagi, MD (1) · Ruben E Alvaro, MD (1) · Waldemar Carlo, MD (1)
PMID 34187829, PMID 40294395, PMID 40929650
U10HD036790 (1), U24HL140412 (1), UG1HD021364 (1), UG1HD027851 (1), UG1HD027853 (1), UG1HD027880 (1), UG1HD027904 (1), UG1HD034216 (1), UG1HD040492 (1), UG1HD040689 (1), UG1HD053089 (1), UG1HD053109 (1), UG1HD068244 (1), UG1HD068263 (1), UG1HD068278 (1)